Align Financial’s ResMed RMD Stock Holding History

Align Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$442	Buy	+2	New	+$436	﹤0.01%	510

Other funds holding RMD

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Align Financial's RMD Position: Q3 2026 in Review

Align Financial opened a new position in ResMed (RMD) in Q3 2026: 2 shares worth $442. The stake represents ﹤0.01% of the portfolio and ranks #510 among its holdings.

145 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Align Financial held 2 shares of ResMed worth $442 as of Q3 2026.
ResMed was a new Align Financial position in Q3 2026.
ResMed made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #510 holding.
145 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.